LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Novavax Inc

Cerrado

SectorSanidad

7.45 6.43

Resumen

Variación precio

24h

Actual

Mínimo

7.34

Máximo

7.47

Métricas clave

By Trading Economics

Ingresos

600M

519M

Ventas

578M

667M

P/B

Media del Sector

2.571

51.198

BPA

2.93

Margen de beneficios

77.798

Empleados

952

EBITDA

569M

516M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+51.01% upside

Dividendos

By Dow Jones

Próximas Ganancias

7 ago 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

130M

1.1B

Apertura anterior

1.02

Cierre anterior

7.45

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

166 / 380 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Novavax Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

2 abr 2025, 17:06 UTC

Principales Movimientos del Mercado

Novavax Falls But Then Recovers After WSJ Report on Vaccine's FDA Status

31 mar 2025, 14:19 UTC

Principales Movimientos del Mercado

Vaccine Stocks Fall After Ousting of FDA's Vaccine Head

4 feb 2025, 18:52 UTC

Principales Movimientos del Mercado

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

11 nov 2024, 14:05 UTC

Principales Movimientos del Mercado

Novavax to Move Forward With Covid-19, Influenza Vaccine After FDA Lifts Clinical Hold

16 oct 2024, 12:59 UTC

Principales Movimientos del Mercado

Novavax Says FDA Puts Clinical Hold on Covid-19, Flu Vaccines; Shares Drop

19 may 2025, 14:30 UTC

Principales Noticias

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker. -- Barrons.com

19 may 2025, 13:27 UTC

Principales Noticias

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker. -- Barrons.com

8 may 2025, 17:55 UTC

Ganancias

Why This Shrinking Covid-19 Vaccine Stock Jumped 30% -- Barrons.com

8 may 2025, 15:12 UTC

Ganancias

Why This Shrinking Covid-19 Vaccine Stock Jumped 30% -- Barrons.com

28 abr 2025, 17:04 UTC

Ganancias

Novavax Stock Is Up Again. There Are Still Big Questions About the Fate of Its Covid Shot. -- Barrons.com

30 dic 2024, 23:02 UTC

Adquisiciones, fusiones, absorciones

Novavax Completes Previously Announced $200M Sale of Czech Republic Manufacturing Site to Novo Nordisk

4 dic 2024, 07:09 UTC

Adquisiciones, fusiones, absorciones

Novavax: Agreement to Close by Dec 30 >NVAX

4 dic 2024, 07:08 UTC

Adquisiciones, fusiones, absorciones

Novavax: Sale Aligns With Plan to Become More Lean Organization, Drive Value From Pipeline Assets & Tech Platform >NVAX

4 dic 2024, 07:07 UTC

Adquisiciones, fusiones, absorciones

Novavax: Deal to Also Reduce Annual Operating Costs by About $80M >NVAX

4 dic 2024, 07:06 UTC

Adquisiciones, fusiones, absorciones

Novavax to Get $190M Cash Payment in 2024, Additional $10M in 2025 >NVAX

4 dic 2024, 07:06 UTC

Adquisiciones, fusiones, absorciones

Novavax: Agreement Provides Company With Significant, Non-Dilutive Capital >NVAX

4 dic 2024, 07:04 UTC

Adquisiciones, fusiones, absorciones

Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200M

15 nov 2024, 13:34 UTC

Principales Noticias

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too -- WSJ

15 nov 2024, 11:14 UTC

Charlas de Mercado

U.S. Vaccine Stocks Fall After Trump Picks Vaccine Skeptic RFK Jr as Health Department Head-- Market Talk

16 oct 2024, 15:22 UTC

Ganancias

These Stocks Are Moving the Most Today: ASML, Nvidia, Morgan Stanley, United Airlines, DJT, Novavax, J.B. Hunt, Cisco, and More -- Barrons.com

Comparación entre iguales

Cambio de precio

Novavax Inc previsión

Precio Objetivo

By TipRanks

51.01% repunte

Estimación a 12 Meses

Media 11.25 USD  51.01%

Máximo 19 USD

Mínimo 7 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Novavax Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

4 ratings

1

Comprar

2

Mantener

1

Vender

Puntuación técnica

By Trading Central

5.692 / 6.039Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Weak Bearish Evidence

Sentimiento

By Acuity

166 / 380 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Novavax Inc

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.